Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myriad Genetics (MYGN) Income towards Parent Company (2016 - 2026)

Myriad Genetics has reported Income towards Parent Company over the past 17 years, most recently at -$7.9 million for Q4 2025.

  • Quarterly Income towards Parent Company rose 81.41% to -$7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$365.9 million through Dec 2025, down 187.43% year-over-year, with the annual reading at -$365.9 million for FY2025, 187.43% down from the prior year.
  • Income towards Parent Company was -$7.9 million for Q4 2025 at Myriad Genetics, up from -$27.4 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $24.6 million in Q3 2021 and troughed at -$330.5 million in Q2 2025.
  • The 5-year median for Income towards Parent Company is -$29.3 million (2023), against an average of -$44.8 million.
  • Year-over-year, Income towards Parent Company soared 261.84% in 2021 and then crashed 800.54% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$7.6 million in 2021, then plummeted by 456.58% to -$42.3 million in 2022, then rose by 26.24% to -$31.2 million in 2023, then tumbled by 36.22% to -$42.5 million in 2024, then soared by 81.41% to -$7.9 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Income towards Parent Company are -$7.9 million (Q4 2025), -$27.4 million (Q3 2025), and -$330.5 million (Q2 2025).